{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:20:42Z","timestamp":1791199242583,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81971909"],"award-info":[{"award-number":["No. 81971909"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFA1303503"],"award-info":[{"award-number":["2022YFA1303503"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05683-w","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T03:39:56Z","timestamp":1733283596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early introduction of IL-10 weakens BCG revaccination\u2019s protection by suppressing CD4+Th1 cell responses"],"prefix":"10.1186","volume":"22","author":[{"given":"Qing","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinge","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengze","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-372X","authenticated-orcid":false,"given":"Xionglin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"5683_CR1","doi-asserted-by":"publisher","unstructured":"Lange C, et al. 100 years of Mycobacterium bovis Bacille Calmette-Gu\u00e9rin. Lancet Infect Dis. 2022;22. https:\/\/doi.org\/10.1016\/S1473-3099(21)00403-5.","DOI":"10.1016\/S1473-3099(21)00403-5"},{"key":"5683_CR2","doi-asserted-by":"publisher","first-page":"e1655","DOI":"10.1016\/S2214-109X(19)30444-9","volume":"7","author":"P Roy","year":"2019","unstructured":"Roy P, et al. Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study. Lancet Glob Health. 2019;7:e1655\u201363. https:\/\/doi.org\/10.1016\/S2214-109X(19)30444-9.","journal-title":"Lancet Glob Health"},{"key":"5683_CR3","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","volume":"8","author":"A Zwerling","year":"2011","unstructured":"Zwerling A, et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012. https:\/\/doi.org\/10.1371\/journal.pmed.1001012.","journal-title":"PLoS Med"},{"key":"5683_CR4","doi-asserted-by":"publisher","unstructured":"Lancione S, Alvarez JV, Alsdurf H, Pai M, Zwerling AA. Tracking changes in national BCG vaccination policies and practices using the BCG World Atlas. BMJ Glob Health. 2022;7. https:\/\/doi.org\/10.1136\/bmjgh-2021-007462.","DOI":"10.1136\/bmjgh-2021-007462"},{"key":"5683_CR5","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/d41586-022-01348-0","volume":"605","author":"S Moutinho","year":"2022","unstructured":"Moutinho S. Tuberculosis is the oldest pandemic, and poverty makes it continue. Nature. 2022;605:S16\u201320. https:\/\/doi.org\/10.1038\/d41586-022-01348-0.","journal-title":"Nature"},{"key":"5683_CR6","unstructured":"Global tuberculosis report 2022, https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports (2022)."},{"key":"5683_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(18)30421-3","volume":"18","author":"LK Schrager","year":"2018","unstructured":"Schrager LK, et al. WHO preferred product characteristics for new vaccines against tuberculosis. Lancet Infect Dis. 2018;18:828\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(18)30421-3.","journal-title":"Lancet Infect Dis"},{"key":"5683_CR8","doi-asserted-by":"publisher","first-page":"e1220","DOI":"10.1016\/S2214-109X(22)00325-4","volume":"10","author":"M Hatherill","year":"2022","unstructured":"Hatherill M, Cobelens F, Infant. BCG vaccination is beneficial, but not sufficient. Lancet Glob Health. 2022;10:e1220\u20131. https:\/\/doi.org\/10.1016\/S2214-109X(22)00325-4.","journal-title":"Lancet Glob Health"},{"key":"5683_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S2213-2600(16)00099-0","volume":"4","author":"BJ Marais","year":"2016","unstructured":"Marais BJ, et al. Interrupted BCG vaccination is a major threat to global child health. Lancet Respir Med. 2016;4:251\u20133. https:\/\/doi.org\/10.1016\/S2213-2600(16)00099-0.","journal-title":"Lancet Respir Med"},{"key":"5683_CR10","first-page":"805","volume":"73","author":"WHO statement on BCG revaccination for the prevention of tuberculosis","year":"1995","unstructured":"WHO statement on BCG revaccination for the prevention of tuberculosis. Bull World Health Organ. 1995;73:805\u20136.","journal-title":"Bull World Health Organ"},{"key":"5683_CR11","first-page":"73","volume":"93","author":"BCG vaccines","year":"2018","unstructured":"BCG vaccines. WHO position paper \u2013 February 2018. Wkly Epidemiol Rec. 2018;93:73\u201396.","journal-title":"Wkly Epidemiol Rec"},{"key":"5683_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","volume":"9","author":"NE Nieuwenhuizen","year":"2018","unstructured":"Nieuwenhuizen NE, Kaufmann SHE. Next-generation vaccines based on Bacille Calmette-Gu\u00e9rin. Front Immunol. 2018;9:121. https:\/\/doi.org\/10.3389\/fimmu.2018.00121.","journal-title":"Front Immunol"},{"key":"5683_CR13","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.vaccine.2012.02.036","volume":"30","author":"MJ Brennan","year":"2012","unstructured":"Brennan MJ, et al. Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine. 2012;30:2811\u201323. https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.036.","journal-title":"Vaccine"},{"key":"5683_CR14","doi-asserted-by":"publisher","unstructured":"Darrah, P. A. et al. Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques. NPJ Vaccines. 2019;4:21. https:\/\/doi.org\/10.1038\/s41541-019-0113-9.","DOI":"10.1038\/s41541-019-0113-9"},{"key":"5683_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes E, et al. Prevention of M. Tuberculosis infection with H4:IC31 vaccine or BCG Revaccination. N Engl J Med. 2018;379:138\u201349. https:\/\/doi.org\/10.1056\/NEJMoa1714021.","journal-title":"N Engl J Med"},{"key":"5683_CR16","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3389\/fimmu.2018.02439","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, et al. Heterologous Boost following Mycobacterium bovis BCG reduces the late persistent, rather than the early stage of Intranasal Tuberculosis Challenge Infection. Front Immunol. 2018;9:2439. https:\/\/doi.org\/10.3389\/fimmu.2018.02439.","journal-title":"Front Immunol"},{"key":"5683_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ebiom.2017.07.005","volume":"22","author":"J Ma","year":"2017","unstructured":"Ma J, et al. A multistage subunit vaccine effectively protects mice against Primary Progressive Tuberculosis, latency and reactivation. EBioMedicine. 2017;22:143\u201354. https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.005.","journal-title":"EBioMedicine"},{"key":"5683_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","volume":"22","author":"RJ North","year":"2004","unstructured":"North RJ, Jung Y-J. Immunity to tuberculosis. Annu Rev Immunol. 2004;22:599\u2013623.","journal-title":"Annu Rev Immunol"},{"key":"5683_CR19","doi-asserted-by":"publisher","unstructured":"Lyadova IV, Panteleev AV. Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators Inflamm 2015, 854507, https:\/\/doi.org\/10.1155\/2015\/854507 (2015).","DOI":"10.1155\/2015\/854507"},{"key":"5683_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/cmi.2017.113","volume":"15","author":"G Zeng","year":"2018","unstructured":"Zeng G, Zhang G, Chen X. Th1 cytokines, true functional signatures for protective immunity against TB? Cell Mol Immunol. 2018;15:206\u201315. https:\/\/doi.org\/10.1038\/cmi.2017.113.","journal-title":"Cell Mol Immunol"},{"key":"5683_CR21","doi-asserted-by":"publisher","first-page":"575504","DOI":"10.3389\/fimmu.2020.575504","volume":"11","author":"L Hao","year":"2020","unstructured":"Hao L, et al. Combinational PRR agonists in liposomal adjuvant enhances immunogenicity and protective efficacy in a tuberculosis subunit vaccine. Front Immunol. 2020;11:575504. https:\/\/doi.org\/10.3389\/fimmu.2020.575504.","journal-title":"Front Immunol"},{"key":"5683_CR22","doi-asserted-by":"publisher","unstructured":"Ullah N et al. Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection. J Immunol Res 2020, 2083793, https:\/\/doi.org\/10.1155\/2020\/2083793 (2020).","DOI":"10.1155\/2020\/2083793"},{"key":"5683_CR23","doi-asserted-by":"publisher","first-page":"e2004433","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, et al. Cytokines: from clinical significance to quantification. Adv Sci (Weinh). 2021;8:e2004433. https:\/\/doi.org\/10.1002\/advs.202004433.","journal-title":"Adv Sci (Weinh)"},{"key":"5683_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","volume":"8","author":"JI Moliva","year":"2017","unstructured":"Moliva JI, Turner J, Torrelles JB. Immune responses to Bacillus Calmette-Gu\u00e9rin vaccination: why do they fail to protect against Mycobacterium tuberculosis? Front Immunol. 2017;8:407. https:\/\/doi.org\/10.3389\/fimmu.2017.00407.","journal-title":"Front Immunol"},{"key":"5683_CR25","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","volume":"10","author":"C Covi\u00e1n","year":"2019","unstructured":"Covi\u00e1n C, et al. BCG-Induced Cross-protection and Development of trained immunity: implication for Vaccine Design. Front Immunol. 2019;10:2806. https:\/\/doi.org\/10.3389\/fimmu.2019.02806.","journal-title":"Front Immunol"},{"key":"5683_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mi.2011.7","volume":"4","author":"PS Redford","year":"2011","unstructured":"Redford PS, Murray PJ, O\u2019Garra A. The role of IL-10 in immune regulation during M. Tuberculosis infection. Mucosal Immunol. 2011;4:261\u201370. https:\/\/doi.org\/10.1038\/mi.2011.7.","journal-title":"Mucosal Immunol"},{"key":"5683_CR27","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/eji.201040433","volume":"40","author":"PS Redford","year":"2010","unstructured":"Redford PS, et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol. 2010;40:2200\u201310. https:\/\/doi.org\/10.1002\/eji.201040433.","journal-title":"Eur J Immunol"},{"key":"5683_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.167.3.1535","volume":"167","author":"RA Silva","year":"2001","unstructured":"Silva RA, Pais TF, Appelberg R. Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J Immunol. 2001;167:1535\u201341.","journal-title":"J Immunol"},{"key":"5683_CR29","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","volume":"189","author":"JM Pitt","year":"2012","unstructured":"Pitt JM, et al. Blockade of IL-10 signaling during bacillus Calmette-Gu\u00e9rin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-\u03b3 and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J Immunol. 2012;189:4079\u201387. https:\/\/doi.org\/10.4049\/jimmunol.1201061.","journal-title":"J Immunol"},{"key":"5683_CR30","doi-asserted-by":"publisher","unstructured":"Xu H, et al. IL-10 dampens the Th1 and tc activation through modulating DC functions in BCG Vaccination. Mediators Inflamm. 2019;2019(8616154). https:\/\/doi.org\/10.1155\/2019\/8616154.","DOI":"10.1155\/2019\/8616154"},{"key":"5683_CR31","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.4049\/jimmunol.0803567","volume":"183","author":"T Schreiber","year":"2009","unstructured":"Schreiber T, et al. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol. 2009;183:1301\u201312. https:\/\/doi.org\/10.4049\/jimmunol.0803567.","journal-title":"J Immunol"},{"key":"5683_CR32","doi-asserted-by":"publisher","first-page":"e0179701","DOI":"10.1371\/journal.pone.0179701","volume":"12","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, et al. Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages. PLoS ONE. 2017;12:e0179701. https:\/\/doi.org\/10.1371\/journal.pone.0179701.","journal-title":"PLoS ONE"},{"key":"5683_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12079-015-0302-x","volume":"10","author":"R Verma","year":"2016","unstructured":"Verma R, et al. A network map of Interleukin-10 signaling pathway. J Cell Commun Signal. 2016;10:61\u20137. https:\/\/doi.org\/10.1007\/s12079-015-0302-x.","journal-title":"J Cell Commun Signal"},{"key":"5683_CR34","doi-asserted-by":"publisher","unstructured":"Ferreira CM, et al. Early IL-10 promotes vasculature-associated CD4\u2009+\u2009T cells unable to control Mycobacterium tuberculosis infection. JCI Insight. 2021;6. https:\/\/doi.org\/10.1172\/jci.insight.150060.","DOI":"10.1172\/jci.insight.150060"},{"key":"5683_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.isci.2018.11.039","volume":"11","author":"C Yuan","year":"2019","unstructured":"Yuan C, et al. Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan induces IL-10-Producing B cells and hinders CD4\u2009+\u2009Th1 immunity. iScience. 2019;11:13\u201330. https:\/\/doi.org\/10.1016\/j.isci.2018.11.039.","journal-title":"iScience"},{"key":"5683_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/cmi.2018.5","volume":"16","author":"K Harling","year":"2019","unstructured":"Harling K, et al. Constitutive STAT3 phosphorylation and IL-6\/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients. Cell Mol Immunol. 2019;16:275\u201387. https:\/\/doi.org\/10.1038\/cmi.2018.5.","journal-title":"Cell Mol Immunol"},{"key":"5683_CR37","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.4049\/jimmunol.2100900","volume":"208","author":"V Dwivedi","year":"2022","unstructured":"Dwivedi V, et al. IL-10 receptor blockade delivered simultaneously with Bacillus Calmette-Gu\u00e9rin vaccination sustains long-term protection against Mycobacterium tuberculosis infection in mice. J Immunol. 2022;208:1406\u201316. https:\/\/doi.org\/10.4049\/jimmunol.2100900.","journal-title":"J Immunol"},{"key":"5683_CR38","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4049\/jimmunol.1901211","volume":"204","author":"EA Wong","year":"2020","unstructured":"Wong EA, et al. IL-10 impairs local Immune response in Lung Granulomas and Lymph Nodes during early Mycobacterium tuberculosis infection. J Immunol. 2020;204:644\u201359. https:\/\/doi.org\/10.4049\/jimmunol.1901211.","journal-title":"J Immunol"},{"key":"5683_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/imr.12965","volume":"301","author":"M Foster","year":"2021","unstructured":"Foster M, et al. BCG-induced protection against Mycobacterium tuberculosis infection: evidence, mechanisms, and implications for next-generation vaccines. Immunol Rev. 2021;301:122\u201344. https:\/\/doi.org\/10.1111\/imr.12965.","journal-title":"Immunol Rev"},{"key":"5683_CR40","doi-asserted-by":"publisher","first-page":"e12843","DOI":"10.1111\/sji.12843","volume":"91","author":"C-H Yuan","year":"2020","unstructured":"Yuan C-H, et al. Mannose-capped lipoarabinomannan-induced B10 cells decrease severity of dextran sodium sulphate-induced inflammatory bowel disease in mice. Scand J Immunol. 2020;91:e12843. https:\/\/doi.org\/10.1111\/sji.12843.","journal-title":"Scand J Immunol"},{"key":"5683_CR41","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1084\/jem.20100265","volume":"207","author":"A Cruz","year":"2010","unstructured":"Cruz A, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med. 2010;207:1609\u201316. https:\/\/doi.org\/10.1084\/jem.20100265.","journal-title":"J Exp Med"},{"key":"5683_CR42","doi-asserted-by":"publisher","unstructured":"Rakshit S, et al. BCG revaccination boosts adaptive polyfunctional Th1\/Th17 and innate effectors in IGRA\u2009+\u2009and IGRA- Indian adults. JCI Insight. 2019;4. https:\/\/doi.org\/10.1172\/jci.insight.130540.","DOI":"10.1172\/jci.insight.130540"},{"key":"5683_CR43","doi-asserted-by":"publisher","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","volume":"13","author":"TJ Scriba","year":"2017","unstructured":"Scriba TJ, et al. Sequential inflammatory processes define human progression from M. Tuberculosis infection to tuberculosis disease. PLoS Pathog. 2017;13:e1006687. https:\/\/doi.org\/10.1371\/journal.ppat.1006687.","journal-title":"PLoS Pathog"},{"key":"5683_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cmi.2017.128","volume":"15","author":"H Shen","year":"2018","unstructured":"Shen H, Chen ZW. The crucial roles of Th17-related cytokines\/signal pathways in M. Tuberculosis infection. Cell Mol Immunol. 2018;15:216\u201325. https:\/\/doi.org\/10.1038\/cmi.2017.128.","journal-title":"Cell Mol Immunol"},{"key":"5683_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","volume":"348","author":"Randomised controlled trial of single BCG","year":"1996","unstructured":"Randomised controlled trial of single BCG. Repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet. 1996;348:17\u201324.","journal-title":"Lancet"},{"key":"5683_CR46","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/s1473-3099(20)30994-4","volume":"21","author":"JR Glynn","year":"2021","unstructured":"Glynn JR, et al. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi. Lancet Infect Dis. 2021;21:1590\u20137. https:\/\/doi.org\/10.1016\/s1473-3099(20)30994-4.","journal-title":"Lancet Infect Dis"},{"key":"5683_CR47","doi-asserted-by":"publisher","first-page":"e1451","DOI":"10.1016\/S2214-109X(21)00309-0","volume":"9","author":"JR Glynn","year":"2021","unstructured":"Glynn JR, et al. BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2021;9:e1451\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(21)00309-0.","journal-title":"Lancet Glob Health"},{"key":"5683_CR48","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","volume":"29","author":"ML Barreto","year":"2011","unstructured":"Barreto ML, et al. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine. 2011;29:4875\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.023.","journal-title":"Vaccine"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05683-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:04:50Z","timestamp":1733285090000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05683-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4715344\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1103"}}